The role of Matrix Metalloproteinase-2 and Galectin-3 as predictive biomarkers for all-cause mortality in patients undergoing transfemoral transcatheter aortic valve implantation.

Kerstin PiaydaJulian Tim HeilemannStanislav KeranovLuisa SchulzMani ArsalanChristoph LiebetrauWon-Keun KimFelix J HofmannPascal BauerSandra VossChristian TroidlSamuel T SossallaChristian W HammHolger M NefOliver Dörr

Published in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2024)

In patients with severe aortic stenosis undergoing transfemoral TAVI, MMP-2 and to a lesser extent Gal-3, seem to have additive value in optimizing risk prediction and streamlining decision-making.

Keyphrases

transcatheter aortic valve implantation
aortic stenosis
transcatheter aortic valve replacement
aortic valve replacement
patients undergoing
decision making
aortic valve
ejection fraction
left ventricular
coronary artery disease
early onset
heart failure